Bacteriostatic versus bactericidal activity of ciprofloxacin in Escherichia coli assessed by flow cytometry using a novel far-red dye
- 16 February 2011
- journal article
- Published by Springer Nature in The Journal of Antibiotics
- Vol. 64 (4) , 321-325
Abstract
As common microbiological methods for the assessment of bacteriostatic or bactericidal activities are very time-consuming, in this work we describe that the use of a novel far-red fluorescent stain, Vybrant DyeCycle Ruby (DCR) for the flow cytometric analysis of fluoroquinolone (ciprofloxacin) bacteriostatic and bactericidal activities in Escherichia coli proved to be specific for bacterial DNA and, after ciprofloxacin exposure, DNA distribution analysis was achieved using a 7.5 μM DCR concentration to stain 5 × 10⁵ ethanol-fixed bacterial cells. The analysis of the bacterial DNA histograms obtained from the ciprofloxacin concentrations tested, enabled the distinction between ciprofloxacin bacteriostatic and bactericidal activities.Keywords
This publication has 26 references indexed in Scilit:
- The Use of DRAQ5 to Monitor Intracellular DNA in Escherichia coli by Flow CytometryJournal of Fluorescence, 2010
- Inter-Cellular Variation in DNA Content of Entamoeba histolytica Originates from Temporal and Spatial Uncoupling of Cytokinesis from the Nuclear CyclePLOS Neglected Tropical Diseases, 2009
- A stable human progesterone receptor expressing HeLa reporter cell line as a tool in chemical evaluation at the different cell-cycle phasesToxicology Letters, 2009
- Microbial drug discovery: 80 years of progressThe Journal of Antibiotics, 2009
- A novel method for long term bone marrow culture and genetic modification of murine neutrophils via retroviral transductionJournal of Immunological Methods, 2009
- Mutant Selection Window Hypothesis UpdatedClinical Infectious Diseases, 2007
- Side Population Analysis Using a Violet-Excited Cell-Permeable DNA Binding DyeStem Cells, 2006
- Clinical Relevance of Bacteriostatic versus Bactericidal Mechanisms of Action in the Treatment of Gram‐Positive Bacterial InfectionsClinical Infectious Diseases, 2004
- Dead Bugs Don’t Mutate: Susceptibility Issues in the Emergence of Bacterial ResistanceEmerging Infectious Diseases, 2003
- Two and three-color fluorescence flow cytometric analysis of immunoidentified viable bacteriaCytometry, 2000